Braveheart Bio Inc. – Filings and Transcripts

NASDAQ: BRVE
Share price (9/29/26): $22.34
Market cap (9/29/26): $2.011 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Registration of securities on exchange

Initial registration of new securities – amended

Ownership Filter

Orbimed Advisors LLC

Orbimed Advisors LLC

Agarwala Vineeta

AH Bio Fund IV, L.P.

Frazier Life Sciences Public Fund, L.P.

News Filter

Reports Second Quarter 2026 Financial Results and Provides Business Update

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Proxies

No filings in this category.

Other Filter

Notice of effectiveness